Icon
+91 94997 68112
Login Register

Omnaris - (0.05 mg/INH; Spray,Metered)

Ciclesonide Nycomed
0.05 mg/INH; Spray,Metered
Less Than $1000 mn
Less Than 5
Less Than 5
None None
None None
treatment of nasal allergy symptoms associated with seasonal allergies in adults and children 6 years of age and older, and with year-round allergies in adults and adolescents 12 years of age and older. It is for use in the nose only
Yes
****** ** ****** ** ** *** *** **** **** ** **** ******* '*** (*** **, ****), '*** (*** **, ****) & '*** (*** **, ****) *** ************ ********* ** *******. ***** *** ** ****** **** ****** ********** *** ******* **** ****** ***** *** ***** ** ********** *** *** *****. ** ** ********* ** **** **** *** ******* ****** ********** *** **** ******* ** *** **, ****. **** ****** ****** ****** ****** *** **, ****.
Omnaris Patent 1 Patent 2 Patent 3 Patent 4 Patent 5
****** ******* ******* ******* *** ********* *** *********
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** *** \ ** *** *, **** ******* **** ***** *** ****
  1. **** **, **** : ****** ******** ******* ***** *** **** ** *********** ******* '***-*** **, ****; '***- *** **, **** *** '***- *** **, ****
  2. ****** *, **** : ******* **** ****** ** ******** ******** ** *******.
  3. *** **, **** : ********** *** ******* **** ****** ***** *** ***** ** ********** *** *** *****.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.